PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Liu, Xian-De, Kong, Wen, Peterson, Christine B, McGrail, Daniel J, Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G, Zhu, Haifeng, Beckermann, Kathryn E, Haake, Scott M, Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M, Lin, Shiaw-Yih, Rathmell, W Kimryn, Jonasch, Eric
Published in Nature communications (01.05.2020)
Published in Nature communications (01.05.2020)
Get full text
Journal Article
Abstract 945: PBRM1 loss reduces IFNγ-STAT1 activity and promotes resistance to immunotherapy and antiangiogenic therapy in renal cell carcinoma
Liu, Xiande, Kong, Wen, Peterson, Christine, Hoang, Anh, Zhang, Xuesong, Zhou, Lijun, Pilie, Patrick, Lam, Truong, Zhu, Haifeng, Isgandrova, Sevinj, Moczygemba, Margie, Jonasch, Eric
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article